Page last updated: 2024-08-21

thiazolidines and Osteoporosis

thiazolidines has been researched along with Osteoporosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deacon, S; Hashimoto, Y; Honda, N; Sekiya, N; Tanaka, M; Yamamoto, M	1
Imagawa, A; Kawabata, K; Kawada, N; Kayasuga, R; Mori, H; Nakanishi, Y; Ochi, Y; Ohmoto, K; Tanaka, M; Yamada, H	1
Deacon, S; Hashimoto, Y; Kuwayama, T; Manako, J; Nagase, S; Ohyama, M; Sharpe, J; Small, M	1
Okazaki, R	1
Boonen, S; Claessens, F; Papapoulos, S; Rosenberg, E; Vanderschueren, D	1

Reviews

2 review(s) available for thiazolidines and Osteoporosis

Article	Year
[Diabetes Mellitus and bone metabolism]. Clinical calcium, 2011, Volume: 21, Issue:5 Topics: Bone and Bones; Diabetes Complications; Diabetes Mellitus; Diphosphonates; Fractures, Bone; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Osteoporosis; Risk; Thiazolidines	2011
Inhibition of cathepsin K for treatment of osteoporosis. Current osteoporosis reports, 2012, Volume: 10, Issue:1 Topics: Alkaline Phosphatase; Animals; Biphenyl Compounds; Bone Density; Bone Remodeling; Bone Resorption; Cathepsin K; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Thiazolidines	2012

Trials

2 trial(s) available for thiazolidines and Osteoporosis

Article	Year
Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns. Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:4 Topics: Aged; Aged, 80 and over; Cathepsin K; Cross-Over Studies; Female; Humans; Middle Aged; Osteoporosis; Thiazolidines	2014
Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women. Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:1 Topics: Aged; Alendronate; Area Under Curve; Bone and Bones; Bone Density; Bone Resorption; Cathepsin K; Collagen Type I; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Middle Aged; Osteoporosis; Postmenopause; Single-Blind Method; Thiazolidines	2015

Article

Year

Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns.

Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:4

Topics: Aged; Aged, 80 and over; Cathepsin K; Cross-Over Studies; Female; Humans; Middle Aged; Osteoporosis; Thiazolidines

2014

Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women.

Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:1

Topics: Aged; Alendronate; Area Under Curve; Bone and Bones; Bone Density; Bone Resorption; Cathepsin K; Collagen Type I; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Middle Aged; Osteoporosis; Postmenopause; Single-Blind Method; Thiazolidines

2015

Other Studies

1 other study(ies) available for thiazolidines and Osteoporosis

Article	Year
ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats. Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:6 Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Cathepsin K; Female; Osteoporosis; Ovariectomy; Rats; Thiazolidines; Tibia	2014